ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2026
An alternative genomic target for proper phylogenetic classification of canine distemper virus (Morbillivirus canis).
Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The high variability of canine distemper virus (CDV) highlights the need for adequate genomic analyses to accurately classify viral variants, with whole-genome sequencing (WGS) being the most recommended strategy for this purpose. However, for practical/economic reasons, CDV variants have often been classified by genetic analysis of the hemagglutinin (H) gene, whose suitability for proper lineage identification has been discussed. Herein, we propose an alternative genomic target for genetic classification of CDV in scenarios in which WGS is not feasible. Initially, we designed high coverage primers to amplify an internal region of the gene previously suggested as a potential target for CDV classification (P/V/C gene). The primers were based on 113 WGS of different CDV lineages available (GenBank) and target a 568 bp amplicon. The putative amplicon was then evaluated in silico for its ability to reproduce the genetic classification by WGS. After this analysis, we optimized the RT-PCR and evaluated its performance by testing different biological samples previously identified as CDV positive. Amplicons generated from these samples were sequenced and phylogenetically analyzed. Our in silico analysis confirmed that the classification based on this amplicon fully reproduces the classification from the CDV WGS. Following this validation, we demonstrated that our primers were able to amplify CDV genetic material from different clinical samples. Finally, the amplicons were easily sequenced by the Sanger method, allowing proper CDV classification. In conclusion, we propose an alternative genomic target for proper phylogenetic classification of CDV, which may be an alternative when WGS is not possible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.